Sunday, July 19, 2026

CMS has issued a new coverage update for laboratory services, explicitly stating that coverage and payment will now depend on the patient's diagnosis code. This formalizes a long-standing expectation but signals increased scrutiny of ICD-10 codes on lab requisitions. Claims lacking a covered diagnosis code for the ordered test will face denial. Practices should audit their lab order workflows now, ensuring front-desk and clinical staff capture accurate, billable diagnosis codes at the point of service. The change affects all Part B lab services.

Major insurers are offering only qualified support for a Trump administration initiative aimed at streamlining prior authorization and denials. While the pledge calls for faster decisions and clearer communication, insurers are signaling that implementation will be gradual and may not apply uniformly across all product lines. This indicates that practices should not expect a sudden, industry-wide easing of authorization burdens. Monitor your major payers' portals for any specific policy bulletins, but maintain current, rigorous authorization workflows.

Molina Healthcare’s Q2 2025 results, released July 19, show steady trading as growth in Medicaid and Affordable Care Act marketplace membership supports earnings. This signals continued enrollment momentum for managed Medicaid plans amid post-pandemic eligibility redeterminations and state expansions. The stock performance reflects market confidence in Molina’s ability to manage medical costs and integrate new membership from recent state contract wins. For practices in Molina states, this financial stability suggests the payer is unlikely to tighten provider payment rates or exit markets in the near term. Monitor Molina’s quarterly medical loss ratio and state-specific enrollment reports for signals of future reimbursement pressure.